"The DOJ believes the acquisition could lead to higher prices in home health care in regions where Amedisys is a main competitor. This raises significant concerns about market competition and patient access to affordable care."
"UnitedHealth claims that the Amedisys combination with its subsidiary, Optum, would be pro-competitive and spur innovation, ultimately improving patient outcomes and access to quality care."
Collection
[
|
...
]